About me

As Senior Counsel working on biotech pharmaceutical patents for Amgen Inc., Antonio Garcia-Rivas handles many important legal matters for the company. Antonio Garcia-Rivas’ work in patents made him an integral member of the legal team for the development of the drug Sensipar(R)/Mimpara(R), a medication used to provide relief for dialysis patients. He procures patents through the United States government and in places such as Europe, Israel, and Mexico. Antonio Garcia-Rivas has prosecuted and drafted patents in such areas as new chemical entities (NCEs), pharmaceutical kits, proteins, polymorphs, and nucleic acids. Antonio Garcia-Rivas involves himself in the license and litigation support of the company’s patents, other intellectual property, and product life cycle management. In South San Francisco, California, Antonio Garcia-Rivas manages Amgen’s legal department and advises executives and subsidiaries on research management, developing patent portfolios, and recognizing strategic opportunities for businesses connected to the creation of patentable material. Although Antonio Garcia-Rivas currently focuses on metabolic disorders, he has also won patents in medical areas such as cancer and cardiovascular disease. At his previous position as Senior Attorney and Therapeutic Leader at Merck Sharp & Dohme Corp., Antonio Garcia-Rivas helped secure the patent for the popular osteoporosis drug FOSAMAX(R).

About my collections

Antonio Garcia-Rivas on BusinessCard2
[Link removed - login to see]
Antonio Garcia-Rivas on Emurse
[Link removed - login to see]
Antonio Garcia-Rivas on BigSight
[Link removed - login to see]
Antonio Garcia-Rivas on CVShare
[Link removed - login to see]

Lists

Recent reviews